Natural Health Trends (NHTC)
(Delayed Data from NSDQ)
$6.85 USD
+0.03 (0.44%)
Updated Aug 27, 2024 09:30 AM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Natural Health Trends Corp falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 44 | 49 | 60 | 62 | 78 |
Cost Of Goods | 11 | 13 | 15 | 17 | 20 |
Gross Profit | 33 | 36 | 45 | 45 | 58 |
Selling & Adminstrative & Depr. & Amort Expenses | 34 | 37 | 43 | 44 | 65 |
Income After Depreciation & Amortization | -2 | 0 | 2 | 1 | -7 |
Non-Operating Income | 2 | 1 | 0 | 1 | 1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 1 | 1 | 2 | 1 | -6 |
Income Taxes | 0 | 0 | 0 | 1 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 1 | 0 | 1 | 1 | -6 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 1 | 0 | 1 | 1 | -6 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -2 | 0 | 2 | 1 | -5 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 2 |
Income After Depreciation & Amortization | -2 | 0 | 2 | 1 | -7 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 11.46 | 11.42 | 11.42 | 11.42 | 10.87 |
Diluted EPS Before Non-Recurring Items | 0.05 | 0.03 | 0.09 | 0.07 | -0.35 |
Diluted Net EPS (GAAP) | 0.05 | 0.03 | 0.09 | 0.07 | -0.52 |
Fiscal Year end for Natural Health Trends Corp falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 10.48 | 10.95 | 10.94 | 10.62 | 10.51 |
Cost Of Goods | 2.70 | 2.91 | 2.79 | 2.69 | 2.67 |
Gross Profit | 7.78 | 8.04 | 8.15 | 7.93 | 7.85 |
SG&A, R&D, and Dept/Amort Expenses | 8.01 | 8.40 | 8.39 | 8.22 | 8.59 |
Income After SG&A, R&D, and Dept/Amort Expenses | -0.23 | -0.36 | -0.24 | -0.29 | -0.74 |
Non-Operating Income | 0.52 | 0.56 | 0.71 | 0.59 | 0.44 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 0.28 | 0.20 | 0.47 | 0.29 | -0.30 |
Income Taxes | 0.11 | 0.01 | 0.11 | 0.12 | -0.08 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 0.17 | 0.19 | 0.36 | 0.17 | -0.22 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 0.17 | 0.19 | 0.36 | 0.17 | -0.22 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 11.48 | 11.47 | 11.46 | 11.45 | 11.43 |
Diluted EPS Before Non-Recurring Items | 0.02 | 0.02 | 0.03 | 0.02 | -0.02 |
Diluted Net EPS (GAAP) | 0.02 | 0.02 | 0.03 | 0.02 | -0.02 |